Intranodal Treatment With Ifnα-Dendritic Cells and Rituximab Induces Systemic Clinical Response and Endogenous Vaccination Against Follicular Lymphoma: Final Result of a Phase I Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.126_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy